Moderate To Severe Chronic Plaque Psoriasis clinical trials

Explore recruiting moderate to severe chronic plaque psoriasis clinical trials.

Recruiting moderate to severe chronic plaque psoriasis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Moderate To Severe Chronic Plaque Psoriasis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter, double-blind, randomized, placebo-controlled, parallel-group, twelve-week treatment proof-of-concept trial to explore the efficacy and safety of IDOR-1117-2520 in adults with moderate to severe chronic plaque psoriasis with or without psoriatic arthritis.

Romania, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Randomized, Placebo and Active Comparator-Controlled Clinical Trial to Study the Efficacy, Safety and Pharmacokinetics (PK) of Tildrakizumab in Pediatric Subjects from 6 to <18 Years of Age with Moderate to Severe Chronic Plaque Psoriasis

Hungary, Slovakia, Spain, Poland

Phase II and Phase III (Integrated) EU CTIS Study details

An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment

Czechia, Spain, Poland, Bulgaria, Italy, Portugal +1 more

Therapeutic use (Phase IV) EU CTIS Study details

Moderate To Severe Chronic Plaque Psoriasis trials by city

Moderate To Severe Chronic Plaque Psoriasis in Toronto Moderate To Severe Chronic Plaque Psoriasis in Vancouver Moderate To Severe Chronic Plaque Psoriasis in Montreal Moderate To Severe Chronic Plaque Psoriasis in Calgary Moderate To Severe Chronic Plaque Psoriasis in Edmonton Moderate To Severe Chronic Plaque Psoriasis in Ottawa Moderate To Severe Chronic Plaque Psoriasis in Winnipeg Moderate To Severe Chronic Plaque Psoriasis in Quebec City Moderate To Severe Chronic Plaque Psoriasis in Hamilton Moderate To Severe Chronic Plaque Psoriasis in Kitchener Moderate To Severe Chronic Plaque Psoriasis in London Moderate To Severe Chronic Plaque Psoriasis in Halifax Moderate To Severe Chronic Plaque Psoriasis in New York Moderate To Severe Chronic Plaque Psoriasis in Los Angeles Moderate To Severe Chronic Plaque Psoriasis in Chicago Moderate To Severe Chronic Plaque Psoriasis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease